We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$3.36B
AUM Growth
+$82M
Cap. Flow
+$65.6M
Cap. Flow %
1.95%
Top 10 Hldgs %
33.03%
Holding
318
New
25
Increased
113
Reduced
72
Closed
11

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$22.7M
2
BURL icon
Burlington
BURL
+$14.9M
3
PRCT icon
Procept Biorobotics
PRCT
+$13.9M
4
DELL icon
Dell
DELL
+$10.2M
5
ASML icon
ASML
ASML
+$7.37M

Top Sells

Rank Stock Value
1
DV icon
DoubleVerify
DV
+$45.6M
2
PGR icon
Progressive
PGR
+$16.3M
3
TDC icon
Teradata
TDC
+$14.4M
4
NFLX icon
Netflix
NFLX
+$13.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$7.45M

Sector Composition

Rank Sector Weight
1 Technology 31.04%
2 Healthcare 18.24%
3 Communication Services 14.1%
4 Financials 12.02%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVH icon
301
Evolent Health
EVH
$348M
$193K 0.01%
10,073
– –
PSLV icon
302
Sprott Physical Silver Trust
PSLV
$12B
$159K ﹤0.01%
16,000
– –
ADT icon
303
ADT
ADT
$5.6B
$76K ﹤0.01%
10,000
– –
ALTM
304
DELISTED
Arcadium Lithium plc
ALTM
$65.3K ﹤0.01%
+19,430
New +$81.2K
VLN icon
305
Valens Semiconductor
VLN
$170M
$31.9K ﹤0.01%
10,000
– –
DNA icon
306
Ginkgo Bioworks
DNA
$528M
$3.46K ﹤0.01%
259
– –
AKTS
307
DELISTED
Akoustis Technologies Inc
AKTS
$1.65K ﹤0.01%
12,500
– –
AGCO icon
308
AGCO
AGCO
$7.4B
– –
-3,664
Closed -$451K
CIM
309
Chimera Investment
CIM
$1.04B
– –
-7,167
Closed -$99.1K
EXAS
310
DELISTED
Exact Sciences
EXAS
– –
-4,451
Closed -$307K
FTNT icon
311
Fortinet
FTNT
$119B
– –
-7,481
Closed -$511K
LULU icon
312
lululemon athletica
LULU
$13.5B
– –
-11,274
Closed -$4.4M
ODFL icon
313
Old Dominion Freight Line
ODFL
$44.1B
– –
-15,439
Closed -$3.39M
ON icon
314
ON Semiconductor
ON
$31.8B
– –
-49,305
Closed -$3.63M
SOAR icon
315
Volato Group
SOAR
$7.24M
– –
-2,145
Closed -$190K
TNC icon
316
Tennant Co
TNC
$1.43B
– –
-5,400
Closed -$657K
YUMC icon
317
Yum China
YUMC
$16.5B
– –
-6,211
Closed -$247K
PXD
318
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-1,196
Closed -$314K
9 10 11 12
13

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Chicago Capital held 318 positions worth $3.36B, up 2.5% from $3.28B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Chicago Capital's Q2 2024 filing shows 25 new, 113 increased, 72 reduced and 11 closed positions. Its largest new stake was Procept Biorobotics: 232,983 shares worth $14.2M. The largest sale was DoubleVerify, an estimated $45.6M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Chicago Capital's largest Q2 2024 buy was Procept Biorobotics: 232,983 shares worth $14.2M.
  • Chicago Capital added most to Ligand Pharmaceuticals in Q2 2024, an estimated $22.7M increase.
  • Chicago Capital's biggest Q2 2024 reduction was DoubleVerify, cutting an estimated $45.6M.
  • Chicago Capital fully exited lululemon athletica in Q2 2024, selling an estimated $4.4M.
  • Chicago Capital's ten largest holdings make up 33% of its $3.36B portfolio in Q2 2024.
  • Chicago Capital opened 25 new positions and closed 11 in Q2 2024.
  • Chicago Capital's portfolio value rose 2.5% quarter-over-quarter to $3.36B.

Based on Chicago Capital's 13F filing for Q2 2024, filed 6 Aug 2024.